Phase I/II – Other

632 trials 274 recruiting

Filter these 632 trials by condition, country, sponsor and more.

Open in Search →

Double-blind placebo-controlled clinical trial (Phase 1b/2a) to evaluate safety and efficacy of IM-250 administration in patients with recur… Recruiting

2024-516368-27-00 Genital herpes infection 2025-01-16
Deferoxamine in Aneurysmal Subarachnoid Hemorrhage trial Recruiting

2024-514615-10-01 Subarachnoid hemorrhage 2025-01-14
MRI contrast agent in the spinal canal to investigate transportation of the cerebrospinal fluid in the brain. Recruiting

2024-520146-33-00 Cerebrospinal fluid circulation disorder seen in clinic 2025-01-13
ACTME Recruiting

2024-516125-31-02 Metastatic Melanoma 2024-12-18
Phase I/II study to evaluate the efficacy and safety of bacterial collagenase administered in patients with Dupuytren's contracture. Recruiting

2023-507332-20-00 Dupuytren contracture 2024-12-18
A clinical study of sacituzumab tirumotecan (sac-TMT) in people with bladder cancer (MK-2870-027) Recruiting

2024-514983-23-01 Intermediate-risk Non-muscle Invasive Bladder Cancer 2024-12-16
A Phase 1b/2, Open-label Study of Amivantamab Monotherapy and Amivantamab in Addition to Other Therapeutic Agents in Participants with Head … Recruiting

2023-508418-40-00 Head and Neck Squamous Cell Carcinoma 2024-12-16
A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Subject… Recruiting

2024-513860-25-00 Ovarian Neoplasms 2024-12-10
Clinical trial of patritumab deruxtecan in people with gastrointestinal cancers Recruiting

2024-512442-41-00 Colorectal Carcinoma, Biliary Tract Carcinoma, Hepatoce 2024-12-03
Tolerogenic dendritic cell therapy in type 1 diabetes; a phase 1b safety and immunological effecitivity study Recruiting

2023-508558-25-01 Type 1 Diabetes 2024-12-02
Phase Ib study combining dinutuximab beta with induction chemotherapy regimens in patients with newly diagnosed high-risk neuroblastoma Recruiting

2023-509673-22-00 Neuroblastoma 2024-12-02
COMparison of B-cell dePletion by rituximAb and anti-CD 19 CAR-T therapy in patients with rhEumatoid arthritis- The COMPARE TRIAL Recruiting

2024-514955-13-00 Rheumatoid Arthritis 2024-11-29
MAGE-C2 TCR T cell therapy Recruiting

2024-516922-70-00 advanced melanoma or HNSCC 2024-11-29
Anti-CD19 CAR T-Cell TherApy in Refractory Systemic Autoimmune DISeases - CATARSIS Recruiting

2024-511293-74-01 Refractory Systemic Autoimmune Diseases 2024-11-26
MEPENDAX: Phase I/II study of axitinib (Inlyta®) and oral metronomic etoposide for pediatric children and AYA with refractory/relapsing medu… Recruiting

2023-509585-38-00 Ependymoma 2024-11-19
An open-label, phase I/II multicenter clinical trial of NECVAX-NEO1 as add-on to first-line neoadjuvant anti-PD-1 monoclonal antibody therap… Recruiting

2024-512520-11-00 Triple negative breast cancer (TNBC) 2024-11-19
mFBG PET-CT for neuroblastoma Recruiting

2022-501694-39-01 (suspision on) Neuroblastoma 2024-11-12
A study of AZD0901 alone or in combination with other anticancer drugs in patients with advanced/metastatic cancer. Recruiting

2023-508275-37-00 Gastric Cancer, Gastroesophageal Junction Cancer, Pancr 2024-11-11
Clinical trial with adipose tissue stem cells for the treatment of hidradenitis suppurativa. Recruiting

2024-516595-15-00 Hidradenitis suppurativa 2024-11-11
LIGHTBEAM-U01-Substudy 01A: A Phase 1/2 Substudy to Evaluate the Safety and Efficacy of Zilovertamab Vedotin in Pediatric and Young Adult Pa… Recruiting

2023-507178-41-00 Hematologic Malignancies or Solid Tumors in Pediatric a 2024-11-07
Phase I/II study assessing radioligand therapy (RLT) using 177Lu-PentixaTher for relapsed/refractory CXCR4+ acute leukemia. Recruiting

2022-501019-15-00 Acute Leukemia 2024-10-22
68Ga-FAPI-46 PET/CT for predicting histological response in triple-negative breast cancer Recruiting

2023-507860-37-00 Breast cancer 2024-10-14
A Phase 2a, dose-finding, randomized, double-blinded, placebo-controlled study to Evaluate the Pharmacodynamics, Pharmacokinetics, and Safet… Recruiting

2023-509613-37-01 Alzheimer's Disease 2024-10-08
A clinical imaging Study of the changes in [18F]F-AraG uptake following Radiotherapy in Non-small cell lung cancer. Recruiting

2024-517960-45-00 Melanoma 2024-10-02